A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia

Peer Review reports

Original Submission
25 Nov 2019	Submitted	Original manuscript
9 Jan 2020	Author responded	Author comments - Usharani Pingali
Resubmission - Version 2
9 Jan 2020	Submitted	Manuscript version 2
17 Mar 2020	Reviewed	Reviewer Report
18 Mar 2020	Reviewed	Reviewer Report - Sajjad Ahmad
2 Apr 2020	Author responded	Author comments - Usharani Pingali
Resubmission - Version 3
2 Apr 2020	Submitted	Manuscript version 3
2 Jun 2020	Reviewed	Reviewer Report
5 Jun 2020	Reviewed	Reviewer Report - Sajjad Ahmad
29 Jun 2020	Reviewed	Reviewer Report
16 Jul 2020	Author responded	Author comments - Usharani Pingali
Resubmission - Version 4
16 Jul 2020	Submitted	Manuscript version 4
10 Aug 2020	Reviewed	Reviewer Report
21 Aug 2020	Reviewed	Reviewer Report - Sajjad Ahmad
1 Sep 2020	Author responded	Author comments - Usharani Pingali
Resubmission - Version 5
1 Sep 2020	Submitted	Manuscript version 5
Publishing
2 Sep 2020	Editorially accepted
15 Sep 2020	Article published	10.1186/s12906-020-03071-7

Back to article page